CD8A and neoplasm: The idea of the study is to transfuse autologous CD4+ and CD8+ T cells that have been genetically modified to express antiFL (anti-Fluorescin CAR-T cells) which can effectively kill tumor cells by marking them with ubiquitin (UB_TT170) beforehand.